In early January, MAPS announced that MAPP2 met pre-specified primary and key secondary endpoints and that it planned to file a new drug application submission in the third quarter of 2023. At the end …
Originally appearing here (Archived)
Summary: Founder and Executive Director of MAPS Rick Doblin discusses a new study that supports the psychedelic MDMA as treatment for PTSD on ‘Kennedy.’ Originally appearing here (Archived) …
Summary: Behavioral Health Business publishes an overview of the increasing popularity of psychedelics due largely to the promising psychedelic-assisted research results taking place. Author Laura Lovett …
Originally appearing here (Archived)
Originally appearing here (Archived)
Summary: Andrew Huberman, Ph.D., mentions MAPS and MAPS Founder and Executive Director Rick Doblin, Ph.D., while being interviewed by Tom Segura on the 2 Bears, 1 Cave (YMHstudios) podcast at 39 minutes …
Originally appearing here (Archived)
Summary: In “Healing in a Sick Society,” an episode of the Audible Original The goop Pursuit, Will Siu, M.D., courageously discusses his healing journey. I join Will to discuss the origins …
Originally appearing here (Archived)
Originally appearing here (Archived)
Originally appearing here (Archived)
